Related Experiment Video
Updated: Sep 17, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
Benjamin Bourgeois1, Emil Spreitzer1, Daniel Platero-Rochart1
1Division of Medicinal Chemistry, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
Abstract:
A central process contributing to the phenotype of aging is cellular senescence. We recently identified the FOXO4 - p53 axis as pivotal in maintaining the viability of senescent cells, and that senescent cells can be targeted selectively with the senolytic peptide FOXO4-DRI. Here, we solve the solution NMR structural models of the p53 transactivation domain in complex with the FOXO4 forkhead domain and in complex with FOXO4-DRI. Strikingly, we find that the disordered FOXO4-DRI binds to the disordered p53TAD2 and forms a transiently folded complex. In this complex, both, the FOXO4-derived region and the cationic cell permeability peptide contribute to the interaction. Furthermore, we show that p53 phosphorylation enhances the affinity for both FOXO4 and FOXO4-DRI. Summarizing we provide a detailed characterization of the interaction of p53 with FOXO4 and FOXO4-DRI which is the basis for development of p53 inhibitors to treat diseases linked to cellular senescence such as cancers.
Insights
Cellular senescence, a hallmark of aging, involves the FOXO4-p53 axis. Researchers structurally characterized the interaction between p53 and FOXO4-DRI, a senolytic peptide, revealing a transiently folded complex crucial for targeting senescent cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Cellular senescence is a key aging process.
- The FOXO4-p53 axis is vital for senescent cell survival.
- Senescent cells can be targeted by the senolytic peptide FOXO4-DRI.
Purpose of the Study:
- To elucidate the structural basis of the interaction between p53 and FOXO4.
- To characterize the complex formed by p53 and the senolytic peptide FOXO4-DRI.
- To provide a foundation for developing p53 inhibitors for senescence-related diseases.
Main Methods:
- Solution Nuclear Magnetic Resonance (NMR) spectroscopy
- Structural modeling
- Biochemical interaction studies
Main Results:
- Solution NMR structures of p53 transactivation domain complexed with FOXO4 forkhead domain and FOXO4-DRI were determined.
- FOXO4-DRI, a disordered peptide, binds to disordered p53TAD2, forming a transiently folded complex.
- Both FOXO4-derived region and cationic cell permeability peptide contribute to the FOXO4-DRI/p53 interaction.
- p53 phosphorylation increases binding affinity for both FOXO4 and FOXO4-DRI.
Conclusions:
- Detailed structural characterization of p53 interactions with FOXO4 and FOXO4-DRI.
- The findings support FOXO4-DRI as a senolytic agent targeting the p53-FOXO4 axis.
- Provides a structural basis for designing novel p53 inhibitors for cancer and aging.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules

